A review on potential of PARP inhibitors in the treatment of prostate cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Egile nagusia: | Islam, Saidul |
---|---|
Beste egile batzuk: | Sharmin, Shahana |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2022
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/17308 |
Antzeko izenburuak
-
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
nork: Karim, Azrin
Argitaratua: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
nork: Flora, Sanzida Alam
Argitaratua: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
nork: Meem, Manila
Argitaratua: (2023) -
Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
nork: Alam, Tahera
Argitaratua: (2024) -
RIPK pathway, as a potential target, for cancer treatment - a review
nork: Jahan, Nusrat
Argitaratua: (2024)